Hop Compounds on the Immune System in Overweight People

Last updated: April 10, 2025
Sponsor: University of Vienna
Overall Status: Active - Recruiting

Phase

N/A

Condition

Obesity

Hypertriglyceridemia

Inflammation

Treatment

Xanthohumol + Iso-alpha Acids

Xanthohumol

Iso-alpha Acids

Clinical Study ID

NCT06745102
UVienna24
  • Ages 18-75
  • All Genders

Study Summary

The aim of the present study is to determine the effect of Iso-alpha Acids and Xanthohumol from hops on the immune response in overweight participants.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • BMI 25 - 29,9 kg/m²

as well as one or more of the following incipient metabolic diseases:

  • pre-diabetes (fasting blood glucose 100-125 mg/dL),

  • fatty liver (grade 1-3),

  • high-normal blood pressure to mild hypertension (grade 1, systolic 140-159 mmHg)

Exclusion

Exclusion Criteria:

  • History of diseases that could falsify the study results

  • inflammatory bowel diseases

  • malignant diseases of the gastrointestinal tract

  • food allergies

  • malabsorption

  • kidney or liver disease (except simple fatty liver)

  • symptomatic heart failure

  • Taking medication to treat these diseases

  • Consumption of special diets (e.g. vegan, gluten-free)

  • Pregnancy

Study Design

Total Participants: 24
Treatment Group(s): 3
Primary Treatment: Xanthohumol + Iso-alpha Acids
Phase:
Study Start date:
February 01, 2024
Estimated Completion Date:
December 30, 2025

Study Description

The aim of the present study is to investigate whether the oral intake of Xanthohumol and Iso-alpha Acids has different protective effects on the immune response of isolated blood cells from overweight people with people with incipient metabolic diseases, what the time course of the effect is and whether the levels of the substances differ from normal-weight individuals.

After taking a fasting blood sample, the study participants receive one of the study drinks and a light breakfast. Both should be consumed within 15 minutes. Further blood samples are taken 1, 2, 3, 4 and 6 hours after the drinks have been consumed. To assess the effect of Xanthohumol and Iso-alpha Acids or a combination of both, clinical parameters, blood lipids, blood glucose, uric acid and inflammatory markers will be determined. Furthermore, blood cells, isolated from blood samples of each time point, will be stimulated for measuring inflammatory markers.

Connect with a study center

  • University of Vienna

    Vienna, 1090
    Austria

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.